Skip to content


Trecondi (treosulfan) is a small molecule pharmaceutical. Treosulfan was first approved as Trecondi on 2019-06-20. It has been approved in Europe to treat hematopoietic stem cell transplantation.
Trade Name Trecondi
Common Name Treosulfan
Indication hematopoietic stem cell transplantation
Drug Class Antineoplastics, alkylating agents (methanesulfonate derivatives)
Get full access now